Statements

  • April 28, 2017

    Leading Women’s Health Organizations Recommend Strategies to Enable Adequate Pain Control and Continued Breastfeeding

    The American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal-Fetal Medicine (SMFM), and The Academy of Breastfeeding Medicine (ABM) released the following statement regarding the U.S. Food and Drug Administration’s (FDA) new guidance on codeine and tramadol in breastfeeding mothers:

  • April 26, 2017

    ACOG Statement on USPSTF Final Recommendations on Screening for Preeclampsia

    “Hypertensive disorders affect five to 10 percent of pregnancies in the United States and can lead to a number of complications, including preterm birth, maternal morbidity and mortality, and long-term risk of maternal cardiovascular disease. ACOG, the leading organization representing the nation’s obstetrician-gynecologists, has always recognized the serious implications of preeclampsia and has convened its own Hypertension in Pregnancy Task Force in the past and issued a report."

  • April 17, 2017

    Medical Groups Unite in Support of Science

    "Fundamental appreciation for scientific evidence is vital, and it begins with access to science education that highlights critical thinking and evidence-based decision-making. Americans need access to education that inspires them to question the world around them and develop new technologies and solutions."

  • April 6, 2017

    ACOG Denounces the Administration's Decision to Deny Funds to the UNPFA

    "Defunding the UNFPA hinders the effectiveness of U.S. global health investments and the growing global progress made in modern family planning. Rather than limit coercive or involuntary reproductive health practices or abortion care, as proposed, this decision will slow the momentum of developing and donor countries that are making tangible headway in closing the gap on access to family planning through increased funding and better policies."

  • March 30, 2017

    ACOG Condemns Senate Vote to Exclude Qualified Providers from Providing Care to Women through Title X

    "The American Congress of Obstetricians and Gynecologists is deeply disappointed in the U.S. Senate’s passage of H.J.Res. 43, allowing state politicians, for the first time, to discriminate against women’s health care providers for reasons unrelated to qualifications or best practices and disqualify health centers, including Planned Parenthood, from providing Title X contraceptive and preventive care to more than four million individuals."

More Statements

View More Statements

Statements Archives

Search previous years statements

Media Relations

Megan Christin
Director, Media Relations
202-863-2423
mchristin@acog.org

Maggie McEvoy 
Manager, Media Relations
202-863-2553
mmcevoy@acog.org

Jamila Vernon
Manager, Media Relations
202-863-2433
jvernon@acog.org

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998